Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks.

Acta Psychiatrica Scandinavica
S N GhaemiR J Baldessarini

Abstract

Long-term antidepressant (AD) treatment for depression in bipolar disorder (BPD) patients is highly prevalent, but its benefits and risks remain uncertain, encouraging this meta-analysis of available research. We reviewed randomized controlled trials for BPD involving >or=6 months of treatment with AD +/- mood stabilizer (MS) vs. placebo +/- MS, using meta-analyses to compare reported risks of new depression vs. mania. In seven trials (350 BPD patients) involving 12 contrasts, long-term treatments that included ADs yielded 27% lower risk of new depression vs. MS-only or no treatment [pooled relative risk, RR = 0.73; 95% CI 0.55-0.97; number-needed-to-treat (NNT) = 11], but 72% greater risk for new mania [RR = 1.72; 95% CI 1.23-2.41; number-needed-to-harm (NNH) = 7]. Compared with giving an MS-alone, adding an AD yielded neither major protection from depression (RR = 0.84; 95% CI 0.56-1.27; NNT = 16) nor substantial increase in risk of mania (RR = 1.37; 95% CI 0.81-2.33; NNH = 16). Long-term adjunctive AD treatment was not superior to MS-alone in BPD, further encouraging reliance on MSs as the cornerstone of prophylaxis.

References

Feb 1, 1988·The American Journal of Psychiatry·T A WehrR W Cowdry
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Apr 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·M Peet
Jan 1, 1996·International Journal of Technology Assessment in Health Care·D MoherP Tugwell
Jan 1, 1996·Depression and Anxiety·N H Kalin
May 20, 1998·The American Journal of Psychiatry·L TondoG Floris
Aug 29, 1998·The Journal of Clinical Psychiatry·L TondoM Tohen
Jun 5, 1999·Journal of Affective Disorders·S N GhaemiK Goodwin
Jun 15, 2000·European Archives of Psychiatry and Clinical Neuroscience·H J Möller, H Grunze
Jan 6, 2001·Psychiatric Services : a Journal of the American Psychiatric Association·C L Bowden
Aug 8, 2001·The Journal of Clinical Psychiatry·S N GhaemiR J Baldessarini
Sep 29, 2001·Journal of Clinical Epidemiology·J A Sterne, M Egger
Jun 5, 2002·Archives of General Psychiatry·Lewis L JuddMartin B Keller
Oct 5, 2002·The Journal of Clinical Psychiatry·Lori L AltshulerMark A Frye
Nov 12, 2003·Archives of General Psychiatry·Mauricio TohenAlan Breier
Nov 25, 2003·The Journal of Clinical Psychiatry·Joseph R CalabreseUNKNOWN Lamictal 605 Study Group
Nov 26, 2003·Bipolar Disorders·S Nassir GhaemiFrederick K Goodwin
Jan 2, 2004·The American Journal of Psychiatry·Mark S Bauer, Landis Mitchner
Jan 2, 2004·The American Journal of Psychiatry·S Nassir GhaemiRoss J Baldessarini
Sep 1, 2004·The American Journal of Psychiatry·Harm J GijsmanGuy M Goodwin
Mar 9, 2005·Archives of Pediatrics & Adolescent Medicine·Ross J BaldessariniJohn Hennen
Jul 5, 2005·The American Journal of Psychiatry·Joseph R CalabreseJamie Mullen
Aug 13, 2005·International Clinical Psychopharmacology·Jay D Amsterdam, Justine Shults
Mar 16, 2006·JAMA : the Journal of the American Medical Association·Mustafa TomaPaul W Armstrong
Jan 9, 2007·Journal of Clinical Epidemiology·Eyal CohenPatricia C Parkin
Jan 12, 2007·Psychiatric Services : a Journal of the American Psychiatric Association·Ross J BaldessariniJohn Hennen
Mar 30, 2007·The New England Journal of Medicine·Gary S SachsMichael E Thase
May 9, 2007·Archives of Pediatrics & Adolescent Medicine·Renee D GoodwinMyrna M Weissman
Jan 18, 2008·Bipolar Disorders·Ross J Baldessarini, Leonardo Tondo
Jan 18, 2008·The New England Journal of Medicine·Erick H TurnerRobert Rosenthal
Oct 4, 2008·Psychiatric Services : a Journal of the American Psychiatric Association·Ross BaldessariniLeslie Leahy

❮ Previous
Next ❯

Citations

Apr 14, 2010·Der Nervenarzt·H Grunze, S Dargel
May 25, 2012·European Archives of Psychiatry and Clinical Neuroscience·Konstantinos N FountoulakisEduard Vieta
Jul 10, 2013·Journal of General Internal Medicine·Joseph M CerimeleJürgen Unützer
Oct 16, 2012·Current Psychiatry Reports·Michelle M Sidor, Glenda M MacQueen
Feb 9, 2013·CNS Spectrums·Laura MusettiLiliana Dell'Osso
Jan 7, 2011·The New England Journal of Medicine·Mark A Frye
May 18, 2010·Journal of Clinical Psychopharmacology·Jay D Amsterdam, Justine Shults
Mar 12, 2010·Child and Adolescent Psychiatry and Mental Health·Erik Parens, Josephine Johnston
Dec 21, 2013·Research in Social & Administrative Pharmacy : RSAP·Manish MittalNancy C Brahm
Jan 1, 2013·International Journal of Bipolar Disorders·Rita BauerMichael Bauer
Sep 6, 2012·Expert Opinion on Pharmacotherapy·Michele FornaroDriss Moussaoui
Jul 19, 2012·Expert Opinion on Drug Metabolism & Toxicology·Peter NiemegeersBernard Gc Sabbe
Aug 13, 2013·Journal of the Chinese Medical Association : JCMA·Ya-Mei BaiTung-Ping Su
Oct 1, 2011·Revista de psiquiatrí́a y salud mental·Oscar HeerenLuis Meza
Nov 26, 2015·Journal of the American Academy of Child and Adolescent Psychiatry·Jay A SalpekarMark A Riddle
Nov 9, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·I PacchiarottiF Colom
Jun 12, 2010·Journal of Affective Disorders·Alessandra M A NivoliEduard Vieta
Apr 16, 2009·Acta Psychiatrica Scandinavica. Supplementum·G S MalhiUNKNOWN CADE Clinic, University of Sydney
Mar 18, 2011·British Journal of Pharmacology·Jared W YoungMark A Geyer
Jul 23, 2013·Bipolar Disorders·Boghos I Yerevanian, Young Mee Choi
Nov 11, 2011·CNS Neuroscience & Therapeutics·Rasmus W Licht
Oct 13, 2011·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Willem A Nolen
Aug 29, 2012·Human Psychopharmacology·Laura S LorenzoRoss J Baldessarini
Jan 11, 2013·Acta Psychiatrica Scandinavica·S Nassir GhaemiE A Whitham
Aug 21, 2012·Acta Psychiatrica Scandinavica·J Phelps, S N Ghaemi
Oct 3, 2014·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Charles L Bowden
Mar 14, 2013·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Heinz GrunzeUNKNOWN WFSBP Task Force on Treatment Guidelines for Bipolar Disorders
Jun 5, 2015·Journal of Affective Disorders·Gustavo H VázquezRoss J Baldessarini
Aug 24, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Giovanni A Fava, Emanuela Offidani
Jul 6, 2013·Journal of Affective Disorders·A KoukopoulosR J Baldessarini
Feb 23, 2013·The International Journal of Neuropsychopharmacology·Gustavo H VázquezRoss J Baldessarini
Dec 9, 2015·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiAjeet B Singh
Apr 18, 2012·The Australian and New Zealand Journal of Psychiatry·Michael J Gitlin
Apr 18, 2012·The Australian and New Zealand Journal of Psychiatry·S Nassir Ghaemi
Feb 10, 2017·Psychotherapy and Psychosomatics·Ross J BaldessariniGustavo H Vázquez
Mar 4, 2017·Acta Psychiatrica Scandinavica·A G SzmulewiczS A Strejilevich
Nov 16, 2017·International Journal of Molecular Sciences·In Hee ShimWon-Myong Bahk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.